Sponsors (14)
The bill directs targeted federal funding, clearer definitions, and more rigorous trials to expand evidence‑based TBI care for veterans, but it increases VA spending and administrative demands, may redirect existing mental‑health resources, and creates a short pilot window that could limit long‑term research and disadvantage smaller providers.
Veterans with mild or chronic traumatic brain injury (TBI) gain expanded access to new, evidence‑based neurorehabilitation treatments through funded clinical trials and pilot programs, potentially improving recovery, quality of life, and mental‑health outcomes.
Researchers, academic centers, nonprofits, and hospitals receive new, dedicated federal funding (multi‑million dollar authorizations across FY2026–FY2028) and grant opportunities to develop and implement neurorehabilitation research and services.
Required randomized controlled trials and independent third‑party administration increase research rigor and can produce clearer standards of care and evidence for effective mTBI treatments.
Taxpayers and the VA budget face increased federal spending (multi‑million dollars) and the bill may rely on or redirect existing VA mental‑health or PTSD center funds, which could reduce resources for other VA priorities or require trade‑offs.
The three‑year pilot/authorization window and per‑grant caps risk interrupting or underpowering longer‑term, multicenter studies, limiting the ability to detect durable outcomes and slowing progress on treatments.
New reporting, oversight, and statutory changes create administrative and transition burdens that could delay grant start‑ups, complicate implementation, and slow VA benefits or services processing.
Based on analysis of 4 sections of legislative text.
Creates two VA grant programs to fund trials and supplemental neurorehabilitation treatments for chronic mTBI in veterans, with multi-year authorizations and reporting requirements through FY2026–FY2028.
Introduced January 9, 2026 by John Bergman · Last progress January 9, 2026
Creates two time-limited VA grant programs to fund research, randomized trials, and supplemental neurorehabilitation treatments for veterans with chronic mild traumatic brain injury (mTBI). The measure directs the VA to award grants to nonprofits, academic institutions, non-VA neurorehabilitation providers, and other eligible entities, sets grant sizes and priorities, requires oversight and annual reporting, and authorizes multi-year funding through FY2026–FY2028. The programs include a larger innovation grant program with individual awards up to $5,000,000 and a second program with specified exploratory and collaborative grant slots; both require independent evaluation, linkage to suicide-prevention efforts, and expire three years after enactment unless renewed.